Disc Medicine Set to Make a Splash at SVB Securities Global Biopharma Conference

John Quisel, J.D., Ph.D., Chief Executive Officer and President of Disc Medicine, Inc. (NASDAQ:IRON), will take part in a virtual fireside chat at the SVB Securities Global Biopharma Conference on Thursday, February 16, 2023 at 8:40 a.m. ET. Disc Medicine is a clinical-stage biopharmaceutical company that is dedicated to uncovering, developing, and commercializing treatments for serious hematologic diseases, striving to provide hope and relief to those suffering from these conditions. Don’t miss this opportunity to hear from one of the individuals at the forefront of the mission to bring new treatments to patients.

About Disc Medicine

At Disc Medicine, we are on a mission to revolutionize the treatment of serious hematologic diseases. Our team of dedicated scientists and clinicians is focused on discovering, developing, and commercializing novel therapies that target the fundamental pathways of red blood cell biology, heme biosynthesis and iron homeostasis, to bring hope to those suffering from hematologic diseases. We are determined to make a difference in the lives of patients by creating innovative, first-in-class therapeutic candidates.

Leave a Comment